Designed For Inhalation: Pulmonary & Nasal Delivery

Source: Catalent

From the top industry partner for development launch and supply of new treatments, Catalent offers integrated solutions for pulmonary and nasal delivery with significant capacity in North America. Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays. With more than 30 years of experience in supporting the development of inhaled and nasal products, from formulation feasibility, process development, spray characterization and clinical supply to commercial filling, packaging and final product testing, our team of experts provide scalable, reliable solutions to support your molecule at any stage in development.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online